These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1691046)

  • 1. High density of zinc-containing and dynorphin B- and substance P-immunoreactive terminals in the marginal division of the rat striatum.
    Shu SY; McGinty JF; Peterson GM
    Brain Res Bull; 1990 Feb; 24(2):201-5. PubMed ID: 1691046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural characteristics of substance P-immunoreactive terminals in marginal division of rat striatum.
    Shu SY; Bao XM; Zhang X
    Chin Med J (Engl); 1991 Nov; 104(11):887-96. PubMed ID: 1724749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin.
    Besson MJ; Graybiel AM; Quinn B
    Neuroscience; 1990; 39(1):33-58. PubMed ID: 1708467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive co-occurrence of substance P and dynorphin in striatal projection neurons: an evolutionarily conserved feature of basal ganglia organization.
    Anderson KD; Reiner A
    J Comp Neurol; 1990 May; 295(3):339-69. PubMed ID: 1693632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructure of the marginal division in the rat striatum.
    Shu SY; Bao XM; Peterson GM
    Chin Med J (Engl); 1992 Feb; 105(2):102-9. PubMed ID: 1597068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 'marginal division': a new subdivision in the neostriatum of the rat.
    Shu SY; Penny GR; Peterson GM
    J Chem Neuroanat; 1988; 1(3):147-63. PubMed ID: 2477034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distribution of dynorphinergic terminals in striatal target regions in comparison to the distribution of substance P-containing and enkephalinergic terminals in monkeys and humans.
    Reiner A; Medina L; Haber SN
    Neuroscience; 1999; 88(3):775-93. PubMed ID: 10363817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential metabolism of dynorphins in substantia nigra, striatum, and hippocampus.
    Sandin J; Tan-No K; Kasakov L; Nylander I; Winter A; Silberring J; Terenius L
    Peptides; 1997; 18(7):949-56. PubMed ID: 9357051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of dynorphin B-like and alpha-neoendorphin-like immunoreactivities in the guinea pig organ of Corti.
    Altschuler RA; Hoffman DW; Reeks KA; Fex J
    Hear Res; 1985 Mar; 17(3):249-58. PubMed ID: 2862132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynorphin-immunoreactive neurons in the rat nucleus accumbens: ultrastructure and synaptic input from terminals containing substance P and/or dynorphin.
    Van Bockstaele EJ; Gracy KN; Pickel VM
    J Comp Neurol; 1995 Jan; 351(1):117-33. PubMed ID: 7534773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats.
    Engber TM; Susel Z; Kuo S; Gerfen CR; Chase TN
    Brain Res; 1991 Jun; 552(1):113-8. PubMed ID: 1717109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor stimulates the release of methionine-enkephalin and dynorphin from the neostriatum and globus pallidus of the rat: in vitro and in vivo studies.
    Sirinathsinghji DJ; Nikolarakis KE; Herz A
    Brain Res; 1989 Jun; 490(2):276-91. PubMed ID: 2569903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat.
    Nylander I; Terenius L
    Brain Res; 1986 Aug; 380(1):34-41. PubMed ID: 2428423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
    Sivam SP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):818-24. PubMed ID: 2476548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The co-occurrence of substance P-like immunoreactivity and dynorphin-like immunoreactivity in striatopallidal and striatonigral projection neurons in birds and reptiles.
    Reiner A
    Brain Res; 1986 Apr; 371(1):155-61. PubMed ID: 2423185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two different types of dynorphin-A-immunoreactive terminals in rat substantia nigra.
    Riesenberg R; Nitsch C
    Cell Tissue Res; 1990 Jul; 261(1):107-13. PubMed ID: 1974480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine modulation of dynorphin B release by hippocampal synaptosomes.
    Loewen JJ; Peters RI; Terrian DM
    Brain Res; 1992 Apr; 577(2):318-20. PubMed ID: 1351416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmental organization of the ventral striatum of the rat: immunohistochemical distribution of enkephalin, substance P, dopamine, and calcium-binding protein.
    Voorn P; Gerfen CR; Groenewegen HJ
    J Comp Neurol; 1989 Nov; 289(2):189-201. PubMed ID: 2478598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of substance P-, enkephalin- and dynorphin-immunoreactive neurons in the medulla of the rat and their contribution to bulbospinal pathways.
    Menetrey D; Basbaum AI
    Neuroscience; 1987 Oct; 23(1):173-87. PubMed ID: 2446203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical distribution of alpha-neo-endorphin/dynorphin neuronal systems in rat brain: evidence for colocalization.
    Weber E; Roth KA; Barchas JD
    Proc Natl Acad Sci U S A; 1982 May; 79(9):3062-6. PubMed ID: 6124001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.